This case report from a Nurse in USA was received at EMD Serono on 10-Apr-2015. 
A 46 year old [estimated age at the time of report] Female patient experienced MIGRAINE, POSITIVE FOR JOHN 
CUNNINGHAM VIRUS after REBIF was started in Apr 2014 for an unknown indication at 44 mcg three times a 
week. Rebif therapy was discontinued in Mar 2015 due to positive for john cunningham virus. 
Events/Outcome: MIGRAINE: Not Reported, POSITIVE FOR JOHN CUNNINGHAM VIRUS: Not Reported.
The reporter did not provide the causality for the events.
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 351 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information